Abstract
Objective. To determine the etiopathogenetic risk factors for the development of infective endocarditis, taking into account demographic and gender characteristics in patients undergoing mitral valve surgery.
Materials and methods. The study included 107 patients who underwent mitral valve surgery. There were 74 men and 33 women. The age of the patients ranged from 20 to 76 years, with a mean age of (50.6 ± 4.8) years. All patients had a history of infective endocarditis with subsequent mitral valve disease. All patients underwent mitral valve repair/prosthetics at the Amosov National Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine. Data from the primary medical records (medical histories, primary medical records, physical, clinical, laboratory and instrumental examinations) were used as the basis for the analysis.
Results. Depending on the surgical treatment performed, patients were divided into two groups: experimental – 67 patients who underwent organ–preserving surgery (mitral valve repair), and control – 40 patients who underwent mitral valve prosthetics. The peculiarities of age and gender distribution of patients with mitral valve disease in the setting of infective endocarditis were studied. The frequency of etiopathogenetic risk factors for the development of infective endocarditis, taking into account the sex of patients in both study groups, was determined.
Conclusions. Determination of etiopathogenetic risk factors for the development of infective endocarditis is extremely important, as it allows to plan surgical treatment and rehabilitation period taking into account all anamnestic features of the patient.
Reference9 articles.
1. Коvalenkо VМ, Nesukay EG, Knyshov GV, Vatutin MT, Voronkov LG, Illiash MG, et al. The diagnosis and treatment of the infectious endo-carditis. The guidelines of the Working Group on Myocardial, Pericardial and Endocardial and Valve Diseases of the Ukrainian Association of Cardiology. Ukrainian Journal of Cardiology. 2015;(6):11-24. Ukrainian.
2. Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017 Jun;103(12):937-44. doi: 10.1136/heartjnl-2015-309102. Epub 2017 Feb 17. PMID: 28213367.
3. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019 Oct 14;40(39):3222-32. doi: 10.1093/eurheartj/ehz620. Erratum in: Eur Heart J. 2020 Jun 7;41(22):2091. PMID: 31504413.
4. Toyoda N, Itagaki S, Egorova NN, Tannous H, Anyanwu AC, El-Eshmawi A, et al. Real-world outcomes of surgery for native mitral valve endocarditis. J Thorac Cardiovasc Surg. 2017 Dec;154(6):1906-12.e9. doi: 10.1016/j.jtcvs.2017.07.077. Epub 2017 Sep 1. PMID: 28942975.
5. Liu PY, Tsai KZ, Lin YP, Lin CS, Zeng HC, Takimoto E, et al. Prevalence and characteristics of mitral valve prolapse in military young adults in Taiwan of the CHIEF Heart Study. Sci Rep. 2021 Feb 1;11(1):2719. doi: 10.1038/s41598-021-81648-z. PMID: 33526804; PMCID: PMC7851121.